(Q42930894)

English

In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008

scientific article published on September 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008 (English)

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

author name string

Yun F. Wayne Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20727474

20 June 2024

Michael J. Dowzicky

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20727474

20 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20727474

20 June 2024

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0732889310001252?httpAccept=text/xml

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

https://api.elsevier.com/content/article/PII:S0732889310001252?httpAccept=text/plain

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

73-79

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Multidrug-resistant Acinetobacter baumannii

1

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Bacteremia caused by Acinetobacter baumannii among patients in critical care

2

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America.

3

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.

4

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline

7

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis

8

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina

10

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.

11

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

12

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method

13

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

14

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

15

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

16

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.

17

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.

18

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Tigecycline: what is it, and where should it be used?

19

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent

20

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

21

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

23

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002.

24

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

25

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Acinetobacter baumannii: emergence of a successful pathogen

26

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest

27

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Rapid development of Acinetobacter baumannii resistance to tigecycline

28

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy

29

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.

30

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05

31

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

33

1 reference

10.1016/J.DIAGMICROBIO.2010.04.002

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.04.002

20 June 2024

Identifiers

10.1016/J.DIAGMICROBIO.2010.04.002

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42930894&oldid=2184405688"